The Moximed MISHA™ knee system is now treating the first commercial patients in the United States. This Implantable shock absorber (ISA) relieves pain and improves function for people who are ineligible for a joint replacement. This article in OrthoSpineNews includes information about the MISHA™ knee system and quotes from Anton Clifford, Ph.D., founder and CEO of Moximed, and Dennis C. Crawford, M.D., Ph.D., Professor of Orthopaedics and Rehabilitation, School of Medicine, Oregon Health and Science University, who treated the first commercial patient.
It also included my comments about how I saw firsthand that an implantable shock absorber can meet a real unmet need in my practice. “My first MISHA case was a 47-year-old female with painful, early OA and a meniscal root tear. The ability to reduce compartment loads with the ISA and concomitantly repair the root without having to cut bone is a significant step toward the goal of providing long term joint preservation. I’m excited to offer this treatment to many OA patients who might benefit from a joint unloading procedure and who demand a shorter path to recovery or the potential for high activity.”